Screen for the HLA-B*5701 allele prior to initiating therapy with EPZICOM [see BOXED WARNING, WARNINGS AND PRECAUTIONS].
The recommended dosage of EPZICOM for adults is one tablet taken orally once daily, in combination with other antiretroviral agents, with or without food.
The recommended oral dose of EPZICOM for pediatric patients weighing at least 25 kg is one tablet daily in combination with other antiretroviral agents [see Clinical Studies]. Before prescribing EPZICOM tablets, pediatric patients should be assessed for the ability to swallow tablets.
Because EPZICOM is a fixed-dose tablet and cannot be dose adjusted, EPZICOM is not recommended for:
Use of EPIVIR® (lamivudine) oral solution or tablets and ZIAGEN® (abacavir) oral solution may be considered.
